Pertussis vaccine adsorbed
Highest phase reached
Phase 3
Drug type
Vaccine component
- Listing at source
- Listed
- Highest phase reached
- Phase 3
- Drug type
- Vaccine component
- Drug name
- Pertussis vaccine adsorbed
- pertussis vaccine adsorbed
- Pertussis vaccine adsorbed
- ChEMBL ID
- CHEMBL2109220
- RxNorm IDs (RxCUI)
- 798302
- First in class
- No
- Orphan designation
- No
- Condition
- Leukemia, Lymphocytic, Chronic, B-Cell
- Highest recorded phase
- 2
- Condition identifier
- EFO:0000095
- Subject identifier
- D015451
- Condition
- HIV Infections
- Highest recorded phase
- 1
- Condition identifier
- EFO:0000764
- Subject identifier
- D015658
- Condition
- Severe Dengue
- Highest recorded phase
- 3
- Condition identifier
- EFO:0004227
- Subject identifier
- D019595
- Condition
- Dengue
- Highest recorded phase
- 3
- Condition identifier
- EFO:0005547
- Subject identifier
- D003715
- Condition identifier
- EFO_0004227
- Highest recorded phase
- 2
- Condition identifier
- MONDO_0004948
- Highest recorded phase
- 2
- NCT00006066
- NCT01187433
- NCT02992418
- NCT02518555
- Prodrug
- No
- Chirality
- Single enantiomer
- Inorganic
- No
- Natural product
- No
Related records
Trials (136)
- 10-year Follow-up After a Single Dose Acellular Pertussis Vaccination
- 2-year Follow-up After a Single Dose Acellular Pertussis Vaccination
- 3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age
- A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)
- A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component)
- A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents
- A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents)
- A Phase II Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents)
- A Study Exploring Whooping Cough Protection in Children and Adults
- A Study of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Diphtheria, Pertussis and Tetanus (Tdap) Viruses Followed by a 2nd Dose of the RSV Vaccine to Healthy Non-Pregnant Women
- A Study of DTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenar™ and Rotarix™ in Healthy Latin American Infants
- A Study of DTaP//PRP-T Combined Vaccine (ACTACEL) Versus Local DTaP and Act-HIB Monovalent Vaccine in Healthy Infants
- A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults
- A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Healthy Japanese Adolescents Aged 11 Years to <13 Years
- A Study on the Safety and Immune Responses to the GVGH altSonflex1-2-3 Vaccine Against Shigellosis in Adults, Children, and Infants
- A Study to Assess the Safety of Adacel® Vaccine
- A Study to Describe the Safety Profile and Compare the Immune Response of 4 Different Formulations of an Investigational Tdap Vaccine When Compared to Licensed Tdap Vaccine in Young Adults in Canada
- A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3111 in Healthy Adults
- A Study to Evaluate the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine in Healthy Non-pregnant Females From 9 to 49 Years of Age
- A Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo
In development for (4)
- B-cell chronic lymphocytic leukemia Phase 2
- Dengue disease Phase 3
- Dengue hemorrhagic fever Phase 3
- HIV infectious disease Phase 1